Yahoo Finance
Search documents
Strawberry Fields REIT price target raised to $16 from $14.50 at Lake Street
Yahoo Finance· 2026-02-24 13:55
Lake Street analyst Mark Smith raised the firm’s price target on Strawberry Fields REIT (STRW) to $16 from $14.50 and keeps a Buy rating on the shares after the company reported Q4 results that were generally ahead of the firm’s expectations. Strawberry Fields has proven its ability to grow through acquisition, says the analyst, who thinks there are “ample opportunities in existing states to acquire new properties and expand.” Published first on TheFly – the ultimate source for real-time, market-moving b ...
HF Sinclair price target lowered to $60 from $65 at BMO Capital
Yahoo Finance· 2026-02-24 13:53
BMO Capital lowered the firm’s price target on HF Sinclair (DINO) to $60 from $65 and keeps an Outperform rating on the shares. The firm is citing the company’s mixed Q4 results, led by weaker refining capture and Lubes, though BMO also sees value in the portfolio high multiple Lubes, Marketing, Midstream businesses and a competitive refining position, the analyst tells investors in a research note. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try ...
Calumet price target raised to $33 from $28 at BofA
Yahoo Finance· 2026-02-24 13:53
BofA analyst Conor Fitzpatrick raised the firm’s price target on Calumet (CLMT) to $33 from $28 and keeps a Buy rating on the shares. The firm updated its model with estimates little changed after a commodity deck refresh and raised its price target as market renewable diesel and sustainable aviation fuel margins continue to rise and support Montana Renewables value. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on ...
Fortress Biotech’s Cyprium enters agreement to sell PRV for $205M
Yahoo Finance· 2026-02-24 13:53
Fortress Biotech (FBIO) and its majority-owned subsidiary, Cyprium Therapeutics announced that Cyprium entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority Review Voucher for gross proceeds of $205M upon the closing of the transaction. In December 2023, Sentynl Therapeutics assumed full responsibility for the development and commercialization of ZYCUBO from Cyprium. The PRV was issued upon approval of ZYCUBO by the U.S. Food and Drug Administration on January 12, 2 ...
How Is NVIDIA's Stock Performance Compared to Other Mega-Cap Stocks?
Yahoo Finance· 2026-02-24 13:53
NVIDIA Corporation (NVDA), headquartered in Santa Clara, California, is a pioneer in gaming GPUs and now leads AI and accelerated computing with a $4.61 trillion market cap. Its data center business surges due to strong demand for Hopper and Blackwell GPUs in AI training and inference, as cloud providers and enterprises ramp up infrastructure investments that exceed supply. NVDA’s shares had reached a 52-week high of $212.19 on Oct. 29, 2025, but are down 9.7% from that level. Due to sustained AI demand ...
Innovative Aerosystems completes acquisition of Moog S-TEC Model 3100 line
Yahoo Finance· 2026-02-24 13:52
Innovative Aerosystems (ISSC) announced it closed the acquisition of the Moog (MOG.B) (MOG.A) S-TEC Model 3100 general aviation fixed wing autopilot product line. “This acquisition represents another important step in our strategy to deliver fully integrated avionics and flight control solutions to the global aerospace market,” said Shahram Askarpour, Chief Executive Officer of Innovative Aerosystems. “By adding this autopilot product line to our portfolio, we are expanding our flight control capabilities, ...
Block price target lowered to $75 from $86 at BofA
Yahoo Finance· 2026-02-24 13:52
BofA lowered the firm’s price target on Block (XYZ) to $75 from $86 and keeps a Buy rating on the shares. The firm cut multiple it applies to its 2027 EPS estimate given lower investor sentiment for payment stocks and lower peer multiples. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on XYZ: Disclaimer & DisclosureReport an Issue ...
Deere price target raised to $730 from $560 at Morgan Stanley
Yahoo Finance· 2026-02-24 13:51
Morgan Stanley raised the firm’s price target on Deere (DE) to $730 from $560 and keeps an Overweight rating on the shares. Despite the year-to-date move in shares and lingering challenges in Ag fundaments, the firm sees near-term and long-term reasons why Deere can continue to outperform, the analyst tells investors. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on DE: Disclaimer & D ...
Warner Bros Discovery is now running a merger auction with a March 20 deadline and Hollywood's future at stake
Yahoo Finance· 2026-02-24 13:51
Warner Bros Discovery is now running a merger auction with a March 20 deadline and Hollywood's future at stake Proactive uses images sourced from Shutterstock Netflix has a signed deal and the cash to defend it. Paramount has a higher bid and a political edge. The Warner Bros board has roughly three weeks to decide which gamble it prefers The bidding war for Warner Bros Discovery Inc (NASDAQ:WBD, XETRA:J5A) has entered its most consequential phase, with a new Paramount offer on the table, an activist inve ...
Epam Systems price target lowered to $220 from $243 at TD Cowen
Yahoo Finance· 2026-02-24 13:50
Core Viewpoint - TD Cowen analyst Bryan Bergin has lowered the price target for Epam Systems (EPAM) to $220 from $243 while maintaining a Buy rating on the shares, indicating a cautious outlook due to client headwinds affecting 2026 growth guidance, but still sees potential for recovery supported by strong fundamentals [1] Group 1: Price Target and Rating - The price target for Epam Systems has been reduced to $220 from $243 [1] - The firm maintains a Buy rating on Epam Systems shares [1] Group 2: Growth Guidance and Challenges - 2026 growth guidance is impacted by a discrete client headwind [1] Group 3: Underlying Fundamentals - AI-driven demand is a positive factor for the company's outlook [1] - Pricing improvement and margin expansion are contributing to a constructive recovery outlook [1] - The company has a strong balance sheet which provides optionality for future growth [1]